ImpediMed has received $15m in funding for five years from SWK Holdings, which is set to enhance its ability to grow and ...

Cidara Therapeutics is leveraging its Cloudbreak platform to develop CD388 for universal influenza prophylaxis. See why I ...

The disappearance of certain CDC data and guidelines from its website last week could hinder the ability or willingness of ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...

Sepsis, a life-threatening organ dysfunction, is responsible for an estimated 1 in 5 deaths globally and 1 in 3 deaths that ...

A renewed focus on the potentially transformative effect of cell and gene therapies (CGTs) will help businesses developing such treatments to attract investment and persuade policymakers to affect ...

whether through online platforms, in physical stores or by delivering the items by hand, the FDA said. People who do so might be fined between NT$30,000 and NT$1 million (US$959 and US$31,966) in ...

HCW9302, leveraging the company's TOBI platform technology ... stating, "The FDA's clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing ...

"I would like to extend a warm welcome to Dan Kirby on behalf of the entire Iovance team,” stated Frederick Vogt, Ph.D., J.D., Interim President, Chief Executive Officer and board member of Iovance.

Commerce Ministry teams with 16 agencies to remove substandard products from e-commerce platforms to protect consumers.

An international lineup of the world’s leading healthcare start-ups competed in the final of the Innov8 competition ...